Raban Jeger, Prof. Dr. med.
Stadtspital Zürich - Klinik für Kardiologie · Stadtspital Triemli Zürich, Division of Cardiology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Raban Jeger, Prof. Dr. med. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:54 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07363161 · BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)B. Braun Melsungen AG · recruiting · Coronary Artery Disease (CAD) · principal investigator
- Ph2NCT05145283 · Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve ImplantationUniversity Hospital, Basel, Switzerland · completed · Acute Ischemic Stroke, Acute Renal Injury · principal investigator
- N/ANCT04881578 · Atrial Fibrillation Before and After Patent Foramen Ovale Closure StudyRaban Jeger · active not recruiting · Cryptogenic Stroke, Foramen Ovale, Patent, Atrial Fibrillation
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.